Financials Zenicor Medical Systems AB

Equities

ZENI

SE0006343984

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-01-30 pm EST 5-day change 1st Jan Change
2.98 SEK -1.32% Intraday chart for Zenicor Medical Systems AB -.--% -6.88%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 106.6 115 82.29 69.32 167.4 115.5
Enterprise Value (EV) 1 111.5 111.9 86.39 75.88 177.9 132.8
P/E ratio -50.2 x -42.5 x -47.9 x 48.6 x 266 x -66.1 x
Yield - - - - - -
Capitalization / Revenue 5.85 x 4.64 x 3.33 x 2.98 x 6.45 x 3.94 x
EV / Revenue 6.12 x 4.51 x 3.49 x 3.26 x 6.86 x 4.53 x
EV / EBITDA -37.4 x -47 x -67.3 x 41.2 x 143 x -184 x
EV / FCF -43.7 x -13 x -13.2 x -25.1 x -42.1 x -21.6 x
FCF Yield -2.29% -7.71% -7.6% -3.98% -2.38% -4.64%
Price to Book 37.6 x 6.49 x 5.15 x 3.98 x 9.27 x 7.09 x
Nbr of stocks (in thousands) 4,636 5,636 5,636 5,636 5,636 5,636
Reference price 2 23.00 20.40 14.60 12.30 29.70 20.50
Announcement Date 5/4/18 4/29/19 4/24/20 4/27/21 5/3/22 4/20/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 18.21 24.79 24.74 23.26 25.94 29.31
EBITDA 1 -2.982 -2.381 -1.284 1.843 1.243 -0.7216
EBIT 1 -3.033 -2.468 -1.373 1.788 1.214 -0.7653
Operating Margin -16.65% -9.95% -5.55% 7.68% 4.68% -2.61%
Earnings before Tax (EBT) 1 -2.126 -2.704 -1.718 1.426 0.6288 -1.747
Net income 1 -2.126 -2.704 -1.718 1.426 0.6288 -1.747
Net margin -11.67% -10.91% -6.94% 6.13% 2.42% -5.96%
EPS 2 -0.4585 -0.4798 -0.3048 0.2529 0.1116 -0.3100
Free Cash Flow 1 -2.554 -8.626 -6.566 -3.019 -4.228 -6.156
FCF margin -14.02% -34.79% -26.54% -12.98% -16.3% -21.01%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/4/18 4/29/19 4/24/20 4/27/21 5/3/22 4/20/23
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 4.91 - 4.1 6.56 10.5 17.3
Net Cash position 1 - 3.08 - - - -
Leverage (Debt/EBITDA) -1.648 x - -3.195 x 3.559 x 8.465 x -23.91 x
Free Cash Flow 1 -2.55 -8.63 -6.57 -3.02 -4.23 -6.16
ROE (net income / shareholders' equity) -54.8% -26.3% -10.2% 8.53% 3.55% -10.2%
ROA (Net income/ Total Assets) -16.8% -8.17% -3.14% 3.62% 2.07% -1.11%
Assets 1 12.68 33.09 54.73 39.41 30.43 157.7
Book Value Per Share 2 0.6100 3.140 2.840 3.090 3.200 2.890
Cash Flow per Share 2 0.0600 1.120 0.4800 0.2100 0.1900 0.1000
Capex 1 0.13 0.04 0.03 0.01 0.06 4.63
Capex / Sales 0.71% 0.17% 0.14% 0.05% 0.23% 15.79%
Announcement Date 5/4/18 4/29/19 4/24/20 4/27/21 5/3/22 4/20/23
1SEK in Million2SEK
Estimates
  1. Stock Market
  2. Equities
  3. ZENI Stock
  4. Financials Zenicor Medical Systems AB